Collaborator and postdoctoral fellow iHEALTH receives important recognition at an international meeting on Magnetic Resonance in Medicine.
Dr. Carlos Milovic, collaborator of the iHEALTH Millennium Institute and a postdoctoral student at University College London, was appointed as a Junior Fellow of the International Society for Magnetic Resonance Imaging in Medicine (ISMRM) for this year 2022.
ISMRM meetings are the largest conferences in the Magnetic Resonance Imaging in Medicine (MRI) community worldwide, and each year thousands of researchers come together to share their scientific advances and to create potential collaborative networks.
During the last annual meeting of the ISMRM, held from May 7 to 12, the names of the researchers, who are starting their careers, recognized with the prestigious recognition of Junior Fellow, were announced. This appointment is made based on their record of publications and participation in the study groups and activities of the Society.
Dr. Milovic, Junior Fellow 2022, commented that “The ISMRM also supports many study groups, focused on particular topics. I am a member of the Electromagnetic Properties of Tissues group, where I served as the elected representative of the student members for the period 2021-2022. This group has also organized its own meetings, workshops and work committees, which allows me to collaborate with the most relevant actors in the field, and participate in very challenging projects.”
Milovic is a collaborator of the iHEALTH Millennium Institute, Ph.D. in Engineering Sciences from the Universidad Católica de Chile, and is currently doing his postdoctoral research in Medical Physics and Biomedical Engineering at University College London, in England. With this recognition you will receive a series of benefits, among which is a mentorship, during the first year, by a senior member of the ISMRM who provides guidance on professional development and the structure, services and opportunities of the ISMRM for social participation.
When asked about his main line of research, Dr. Milovic comments that it consists of Quantitative Magnetic Susceptibility Maps (QSM). He then explains that MRI is a tremendously flexible and powerful imaging technology. With it, it is possible to measure different properties of the tissues and the space that surrounds them. “In particular, we (at QSM) are interested in measuring the magnetization of the tissues when they are inside the magnetic resonator. In general, materials generate a magnetic field that opposes or contributes to a strong external field applied to them. The degree to which they oppose or contribute depends on the magnetic susceptibility of the material, which in turn is related to the physical properties and chemical composition of its components.”
Thus, measuring the susceptibility of human tissue can be used as a very good indicator of the presence of iron, calcifications, or other processes such as myelin loss in white matter. These indicators can be used as biomarkers in studies that try to understand aging processes, and also to study or diagnose neurodegenerative diseases such as Alzheimer’s, Parkinson’s or Multiple Sclerosis.
“My research provides new methods to perform this quantification of magnetic susceptibility of tissues, with the purpose of making them more robust and reliable for clinical use. And in that sense, Deep Learning is becoming one of the technologies that promises to revolutionize the way we work. My intention within iHEALTH is to promote the use of Deep Learning technologies and optimize them for Quantitative Magnetic Susceptibility Maps (QSM) and other new applications,” Milovic concluded.